ES2174748A1 - Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos. - Google Patents

Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos.

Info

Publication number
ES2174748A1
ES2174748A1 ES200100273A ES200100273A ES2174748A1 ES 2174748 A1 ES2174748 A1 ES 2174748A1 ES 200100273 A ES200100273 A ES 200100273A ES 200100273 A ES200100273 A ES 200100273A ES 2174748 A1 ES2174748 A1 ES 2174748A1
Authority
ES
Spain
Prior art keywords
polymorphs
thiazolidinedione
obtaining
new salt
antidiabetic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200100273A
Other languages
English (en)
Other versions
ES2174748B1 (es
Inventor
S A Vita-Invest
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vita Invest SA
Original Assignee
Vita Invest SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES200100273A priority Critical patent/ES2174748B1/es
Application filed by Vita Invest SA filed Critical Vita Invest SA
Priority to HU0302871A priority patent/HUP0302871A2/hu
Priority to SK955-2003A priority patent/SK9552003A3/sk
Priority to EEP200300356A priority patent/EE200300356A/xx
Priority to APAP/P/2003/002832A priority patent/AP1281A/en
Priority to KR10-2003-7009880A priority patent/KR20030078893A/ko
Priority to MXPA03006722A priority patent/MXPA03006722A/es
Priority to BR0206850-8A priority patent/BR0206850A/pt
Priority to IL15702802A priority patent/IL157028A0/xx
Priority to CNA028043863A priority patent/CN1694881A/zh
Priority to CA002436556A priority patent/CA2436556A1/en
Priority to ZA200305873A priority patent/ZA200305873B/en
Priority to NZ527677A priority patent/NZ527677A/en
Priority to YU60303A priority patent/YU60303A/sh
Priority to JP2002561467A priority patent/JP2004529870A/ja
Priority to EA200300842A priority patent/EA200300842A1/ru
Priority to US10/470,980 priority patent/US20040106632A1/en
Priority to CZ20032015A priority patent/CZ20032015A3/cs
Priority to PL02362527A priority patent/PL362527A1/xx
Priority to EP02716216A priority patent/EP1355908A1/en
Priority to PCT/IB2002/000229 priority patent/WO2002060899A1/en
Priority to PE2002000054A priority patent/PE20020969A1/es
Priority to ARP020100291A priority patent/AR042584A1/es
Publication of ES2174748A1 publication Critical patent/ES2174748A1/es
Priority to IS6896A priority patent/IS6896A/is
Priority to NO20033375A priority patent/NO20033375L/no
Priority to MA27262A priority patent/MA26988A1/fr
Priority to BG108047A priority patent/BG108047A/bg
Publication of ES2174748B1 publication Critical patent/ES2174748B1/es
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabéticos y procedimiento para la obtención de los mismos. Se refiere a una nueva sal de tiazolidindiona y a sus polimorfos que presentan una actividad hipoglucemiante elevada y, que por lo tanto, son potencialmente útiles en el tratamiento y/o profilaxis de la diabetes y/o otras alteraciones o complicaciones propias de la diabetes como hiperglicemia o hiperlipidemia. También se refiere a un procedimiento para la obtención de los mismos.
ES200100273A 2001-01-31 2001-01-31 Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos. Expired - Fee Related ES2174748B1 (es)

Priority Applications (27)

Application Number Priority Date Filing Date Title
ES200100273A ES2174748B1 (es) 2001-01-31 2001-01-31 Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos.
CZ20032015A CZ20032015A3 (cs) 2001-01-31 2002-01-21 Nová sůl thiazolidindionu a její polymorfy jako antidiabetická činidla a metoda jejich získávání
EA200300842A EA200300842A1 (ru) 2001-01-31 2002-01-21 Новая соль тиазолидиндиона и ее полиморфные формы в качестве противодиабетических средств и способ их получения
APAP/P/2003/002832A AP1281A (en) 2001-01-31 2002-01-21 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and methods for obtaining them.
KR10-2003-7009880A KR20030078893A (ko) 2001-01-31 2002-01-21 항당뇨병제로서 티아졸리딘디온의 신규한 염 및 이의동질이상체 및 이들을 수득하는 방법
MXPA03006722A MXPA03006722A (es) 2001-01-31 2002-01-21 Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y metodo para la obtencion de los mismos.
BR0206850-8A BR0206850A (pt) 2001-01-31 2002-01-21 Sal de tiazolidinadiona e seus polimorfos como agentes antidiabéticos e método pata obtê-los
IL15702802A IL157028A0 (en) 2001-01-31 2002-01-21 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
CNA028043863A CN1694881A (zh) 2001-01-31 2002-01-21 新的用作抗糖尿病药的噻唑烷二酮的盐和它的多晶型物以及获得它们的方法
CA002436556A CA2436556A1 (en) 2001-01-31 2002-01-21 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
ZA200305873A ZA200305873B (en) 2001-01-31 2002-01-21 New salt of thiazolidinedione and its polymorphs as anti-diabetic agents and method for obtaining them.
SK955-2003A SK9552003A3 (en) 2001-01-31 2002-01-21 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
YU60303A YU60303A (sh) 2001-01-31 2002-01-21 Nova so tiazolidindiona i njeni polimorfni oblici kao antidijabetički agensi i postupak za njihovo dobijanje
JP2002561467A JP2004529870A (ja) 2001-01-31 2002-01-21 抗糖尿病薬としてのチアゾリジンジオンの新規塩およびその多形体ならびにその製造方法
HU0302871A HUP0302871A2 (hu) 2001-01-31 2002-01-21 Tiazolidindion és polimorf módosulatai új sója, eljárás előállítására, ezeket tartalmazó diabetes elleni szerek
EEP200300356A EE200300356A (et) 2001-01-31 2002-01-21 Tiasolidiindiooni sool ja selle polümorfid kui diabeedivastased ained ning nende valmistamise meetod
US10/470,980 US20040106632A1 (en) 2001-01-31 2002-01-21 Salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
PL02362527A PL362527A1 (en) 2001-01-31 2002-01-21 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
EP02716216A EP1355908A1 (en) 2001-01-31 2002-01-21 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
PCT/IB2002/000229 WO2002060899A1 (en) 2001-01-31 2002-01-21 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
NZ527677A NZ527677A (en) 2001-01-31 2002-01-21 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
PE2002000054A PE20020969A1 (es) 2001-01-31 2002-01-24 Sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos
ARP020100291A AR042584A1 (es) 2001-01-31 2002-01-28 Sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos
IS6896A IS6896A (is) 2001-01-31 2003-07-28 Nýtt salt þíasólidíndíóns og fjölgervingar þess sem andsykursýkismiðlar og aðferð til að öðlast þá
NO20033375A NO20033375L (no) 2001-01-31 2003-07-28 Nye salter av tiazolidindion og dets polymorfer som antidiabetiske midler og fremgangsmåter for å oppnå dem
MA27262A MA26988A1 (fr) 2001-01-31 2003-07-31 Nouveau sel de la thiazolidinedione et ses varietes polymorphiques en tant qu'agents antidiabetiques et methode pour les obtenir.
BG108047A BG108047A (bg) 2001-01-31 2003-08-01 Нова 'ол на 'иазолидиндион и н...йни полимор"и ка'о про'иводиаб...'и-ни 'р...д''ва и м...'од за пол"-аван...'о им

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200100273A ES2174748B1 (es) 2001-01-31 2001-01-31 Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos.

Publications (2)

Publication Number Publication Date
ES2174748A1 true ES2174748A1 (es) 2002-11-01
ES2174748B1 ES2174748B1 (es) 2003-09-16

Family

ID=8496644

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200100273A Expired - Fee Related ES2174748B1 (es) 2001-01-31 2001-01-31 Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos.

Country Status (27)

Country Link
US (1) US20040106632A1 (es)
EP (1) EP1355908A1 (es)
JP (1) JP2004529870A (es)
KR (1) KR20030078893A (es)
CN (1) CN1694881A (es)
AP (1) AP1281A (es)
AR (1) AR042584A1 (es)
BG (1) BG108047A (es)
BR (1) BR0206850A (es)
CA (1) CA2436556A1 (es)
CZ (1) CZ20032015A3 (es)
EA (1) EA200300842A1 (es)
EE (1) EE200300356A (es)
ES (1) ES2174748B1 (es)
HU (1) HUP0302871A2 (es)
IL (1) IL157028A0 (es)
IS (1) IS6896A (es)
MA (1) MA26988A1 (es)
MX (1) MXPA03006722A (es)
NO (1) NO20033375L (es)
NZ (1) NZ527677A (es)
PE (1) PE20020969A1 (es)
PL (1) PL362527A1 (es)
SK (1) SK9552003A3 (es)
WO (1) WO2002060899A1 (es)
YU (1) YU60303A (es)
ZA (1) ZA200305873B (es)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002953A (en) * 1987-09-04 1991-03-26 Beecham Group P.L.C. Novel compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1183130C (zh) * 1999-09-24 2005-01-05 中国人民解放军军事医学科学院毒物药物研究所 噻唑烷类衍生物及其医药用途
ES2156574B1 (es) * 1999-11-18 2002-02-01 Vita Invest Sa Nuevos derivados de tiazolidindiona como agentes antidiabeticos

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002953A (en) * 1987-09-04 1991-03-26 Beecham Group P.L.C. Novel compounds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CANTELLO, BARRIE C.C. y col. [[Gamma-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as Potent Antihyperglycemic Agents. J. Med. Chem., Octubre 1994, Vol. 37, No 23, paginas 3977-85. Pagina 3980, tabla 2, compuestos 32-35; esquema 1. *
HULLIN, B. y col. The glitazone Family of Antidiabetic Agents. Current Pharmaceutical Design, 1996, Vol. 2, paginas 85-102. Pagina 88, tabla IV, compuestos 27-31. *

Also Published As

Publication number Publication date
AR042584A1 (es) 2005-06-29
US20040106632A1 (en) 2004-06-03
CN1694881A (zh) 2005-11-09
YU60303A (sh) 2006-05-25
KR20030078893A (ko) 2003-10-08
NO20033375D0 (no) 2003-07-28
PE20020969A1 (es) 2002-12-04
WO2002060899A1 (en) 2002-08-08
PL362527A1 (en) 2004-11-02
ES2174748B1 (es) 2003-09-16
BR0206850A (pt) 2004-01-13
AP1281A (en) 2004-05-25
AP2003002832A0 (en) 2003-09-30
CA2436556A1 (en) 2002-08-08
HUP0302871A2 (hu) 2003-12-29
ZA200305873B (en) 2004-07-30
SK9552003A3 (en) 2004-05-04
BG108047A (bg) 2004-08-31
JP2004529870A (ja) 2004-09-30
MXPA03006722A (es) 2004-10-15
EA200300842A1 (ru) 2004-04-29
NO20033375L (no) 2003-08-22
NZ527677A (en) 2005-01-28
IL157028A0 (en) 2004-02-08
EE200300356A (et) 2003-10-15
IS6896A (is) 2003-07-28
CZ20032015A3 (cs) 2004-02-18
EP1355908A1 (en) 2003-10-29
MA26988A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
WO2004050645A8 (en) Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
NO20051103L (no) Indol-3-karboksamider som Glukokinase-(GK)-Aktivatorer
WO2006012395A3 (en) Peptidase inhibitors
RS93604A (en) Substituted phenylacetamides and their use as glucokinase activators
MY141521A (en) 5-substituted-six-membered heteroaromatic glucokinase activators
CA2407416A1 (en) Alkynyl phenyl heteroaromatic glucokinase activators
MY148809A (en) Crystals of 1,2-dihydropyridine compound and their production process
TW200738136A (en) Fungicidal N-[2-(haloalkoxy)phenyl]heteroarylcarboxamides
WO2005012318A3 (en) Substituted fused heterocyclic c-glycosides
MY136926A (en) Glucokinase activators
PL371582A1 (en) Difluoromethyl thiazolyl carboxanilides
MXPA04000622A (es) Pirazolilcarboxanilidas como funguicidas.
UA85569C2 (ru) Замещенные конденсированные гетероциклические с-гликозиды
UA81659C2 (ru) Моноклинный 2-хлор-n-(4'-хлорбифенил-2-ил)никотинамид, способ его получения, фунгицидное средство и способ борьбы с вредными грибами
IL120443A0 (en) Heterocyclic compounds for the treatment of pancreatitis
ATE457982T1 (de) Thiazol-(bi)cycloalkyl-carboxanilide
ES2174748A1 (es) Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos.
AU2002246317A1 (en) Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof
EP1251847A4 (en) NEW USE OF PRODIGIOSIN FOR THE TREATMENT OF DIABETES MELLITUS
RS20060263A (en) Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer
MXPA03012073A (es) Amidoderivados heterociclicos.
RS20060321A (en) Substituted fused heterocyclic c-glycosides

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20021101

Kind code of ref document: A1

Effective date: 20021101

FG2A Definitive protection

Ref document number: 2174748B1

Country of ref document: ES

FD1A Patent lapsed

Effective date: 20100312